secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acadia Healthcare Company, Inc. (ACHC)
CIK:        0001520697
Form:       8-K
Filed at:   2026-01-20T23:59:59+00:00
Accession:  0001437749-26-001486
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acadia Healthcare appoints former CEO Debra Osteen as CEO; Chris Hunter departs
-------------------------------------------------------------------------------

- Debra Osteen appointed CEO and Class I director effective January 20, 2026; previously served as CEO from 2018-2022.
- Chris Hunter departed as CEO and resigned from Board effective January 20, 2026; separation agreement terms to be disclosed later.
- Osteen receives base salary of $1,061,000, target bonus of 125% of salary, and option to purchase 1,125,000 shares with performance-based vesting.
- Company reaffirms FY 2025 guidance: revenue $3.28B-$3.30B, Adjusted EBITDA $601M-$611M, adjusted EPS $1.94-$2.04.
- Board will conduct a comprehensive search for a long-term successor while evaluating all paths to enhance shareholder value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1520697/000143774926001486/0001437749-26-001486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1520697/000143774926001486/achc20260119_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-001486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer